JP Morgan Chase
VIR icon

JP Morgan Chase’s Vir Biotechnology VIR Stock Holding History

JP Morgan Chase’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,000
Closed -$294K – 7758
2024
Q4 		$294K Buy
+40,000
New +$316K ﹤0.01% 5306
2023
Q4 		– Sell
-30,000
Closed -$281K – 7893
2023
Q3 		$281K Sell
30,000
-133,800
-82% -$1.91M ﹤0.01% 4838
2023
Q2 		$4.02M Buy
163,800
+84,000
+105% +$2.11M ﹤0.01% 3041
2023
Q1 		$1.86M Buy
+79,800
New +$2.04M ﹤0.01% 3594
2021
Q3 		– Sell
-128,900
Closed -$6.09M – 6834
2021
Q2 		$6.09M Sell
128,900
-21,100
-14% -$959K ﹤0.01% 2881
2021
Q1 		$7.69M Buy
+150,000
New +$8.08M ﹤0.01% 2601

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

JP Morgan Chase's VIR Position: Q1 2026 in Review

JP Morgan Chase increased its Vir Biotechnology (VIR) stake by 167% in Q1 2026, buying an estimated $5.57M and bringing the position to 1,117,516 shares worth $9.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2735.

JP Morgan Chase first reported a position in VIR in Q4 2019 and has held it in 26 quarters since. The position peaked at $13.3M in Q4 2024. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • JP Morgan Chase held 1,117,516 shares of Vir Biotechnology worth $9.45M as of Q1 2026.
  • JP Morgan Chase bought 698,913 Vir Biotechnology shares in Q1 2026, an estimated $5.57M.
  • Vir Biotechnology made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2735 holding.
  • JP Morgan Chase first reported a position in Vir Biotechnology in Q4 2019 and has held it in 26 quarters since.
  • JP Morgan Chase's Vir Biotechnology position peaked at $13.3M in Q4 2024.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.